Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 215181

In scope icon M 1 A
QID 215181 (Type "215181" in App Search)
A 40-year-old woman presents to the clinic for consideration of a kidney transplant. The patient has a history of end-stage renal disease secondary to chronic obstructive uropathy. She is on intermittent hemodialysis and takes lisinopril. She does not smoke or drink alcohol. She has a stable home environment and strong support network. The patient’s temperature is 96.8°F (37.0°C), blood pressure is 134/82 mmHg, pulse is 68/min, and respirations are 16/min. There is 2+ pitting edema of her lower extremities. The post-transplant immunosuppressive regimen is explained to the patient, which includes a drug that is converted into its active metabolite 6-mercaptopurine (6-MP) by the body. What is the primary mechanism of action of this drug?